Cargando…
Bioequivalence study between two formulations of ciclosporin A (Cyclavance® oral solution and Atopica® soft capsules) following a single oral administration to dogs
BACKGROUND: Ciclosporin is a selective immunomodulator used for the treatment of atopic dermatitis in dogs. A new 100 mg/ml oral solution formulation (Cyclavance®, Virbac) was developed as a pharmaceutical equivalent to the marketed capsule formulations (Atopica®, Novartis Animal Health) containing...
Autores principales: | Navarro, C., Séguy, L., Vila, M., Birckel, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789266/ https://www.ncbi.nlm.nih.gov/pubmed/26970736 http://dx.doi.org/10.1186/s12917-016-0669-9 |
Ejemplares similares
-
Preliminary Bioequivalence of an Oral Pimobendan Solution Formulation with Reference Solution Formulation in Beagle Dogs
por: Saengklub, Nakkawee, et al.
Publicado: (2022) -
Voluntary acceptance and consumption of two oral ciclosporin formulations in dogs: two randomised, controlled studies
por: Navarro, Christelle, et al.
Publicado: (2015) -
Comparative study to evaluate the voluntary acceptance of two liquid oral formulations of ciclosporin in dogs
por: Kammanadiminti, Srinivas J., et al.
Publicado: (2018) -
Safety, tolerability, and pharmacokinetics of 6-month daily dosing of an oral formulation of cyclosporine (ATOPICA for cats®) in cats
por: Roberts, E S, et al.
Publicado: (2014) -
Bioequivalence of Orally Administered Generic, Compounded, and Innovator‐Formulated Itraconazole in Healthy Dogs
por: Mawby, D.I., et al.
Publicado: (2013)